… Autoimmune blistering diseases (AIBD) are a group of rare but potentially fatal … published
case–control studies focussing on the non-genetic aetiological factors of bullous pemphigoid, …

… Autoimmune Blistering Diseases are often treated with systemic corticosteroids initially
followed by steroid sparing agents. Patients are assessed for co-morbidities such as diabetes, …

… Linear IgA dermatosis is the most common autoimmune blistering disease in children. It
can clinically resemble BP (anti-laminin-γ1 pemphigoid, also known as anti-p200 pemphigoid, …

… Autoimmune bullous diseases have a broad … skin blister formation — intraepidermal or
subepidermal, they can be classified into pemphigus group and pemphigoid group of diseases …

… made in refining standardized disease severity scores for autoimmune blistering diseases. …
been reported to a lesser extent in subepidermal autoimmune blistering diseases (s-AIBDs). …

… that target autoantibodies which contribute to disease symptoms. This review will outline …
autoimmune blistering diseases by describing the mechanisms underpinning skin autoimmunity …

… The use of skin substrates deficient in basement membrane molecules for the diagnosis
of subepidermal autoimmune bullous disease. Eur J Dermatol EJD. (1998) 8:83–5. …

… the therapeutic armentarium for these partly life-threatening diseases. In this review, the
focus is on autoimmune bullous diseases with the skin as the major target which involve …

… These data had to be retrieved from numerous case reports and case control studies,
only 3 of them included more than 10 patients [112, 113, 115]. So far no prospective …

… Outcome measures are crucial in assessing an autoimmune blistering disease's (AIBD)
severity as well as its impact on the patient's quality of life (QOL). The standardization of AIBD …